CDKN2A and melanoma: The increased expression of EZH2 in melanoma results in the hyper-activation of PRC2 with consequent tri-methylation of H3K27, silencing of CDKN2A and CDKN1A tumor suppressor genes, and is associated with thicker primary melanomas, aggressive metastatic behavior, and a poor prognosis [77].